Updated Jul 16, 2026
Shiferman Gregory L. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-03 | VYGR | Voyager Therapeutics, Inc. | A — Grant or award | 50.0K | $0.00 | |
| 2025-07-31 | SAGE | Sage Therapeutics, Inc. | D — Derivative transaction | 23.7K | — | |
| 2025-07-31 | SAGE | Sage Therapeutics, Inc. | J — Other acquisition / disposition | 7.2K | — | |
| 2024-12-27 | SAGE | Sage Therapeutics, Inc. | F — Tax withholding / forfeiture | 79 | $5.48 | $433 |
| 2024-11-01 | SAGE | Sage Therapeutics, Inc. | A — Grant or award | 5.0K | $0.00 |
Shiferman Gregory L. is a corporate insider — currently tracked as SVP and General Counsel. InsiderAlpha tracks every SEC Form 4 filing in real time.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Shiferman Gregory L. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.